Page 6 - Broadcast Date News Today

In this GEN webinar, our distinguished presenter, Dr. Eric Abbate, will demonstrate a novel multiplexed genome-wide editing approach to optimize the cellobiohydrolase I enzyme (CBH1) production in S. cerevisiae.

In this GEN webinar, our distinguished speaker, Dr. Manuel Kaulich, CSO of Vivlion and group leader at Goethe University, will show us how CRISPR gene editing and functional genetic screening can be used to identify co-dependencies and functional genetic maps, focusing on the key technological advancements that make human combinatorics possible.

In this GEN webinar, our distinguished presenter will provide insight into a novel mass photometry instrument tailored to address the challenges of AAV characterization.

Join us for this GEN webinar, where our expert panelists will take you through the downstream process of AAV purification and the characterization steps associated with process development and their application in manufacturing lot release testing.

Join us for this exciting GEN Live as we discuss some of the latest developments in neuro-drug discovery with experts across the academic and life sciences industry.

In this GEN webinar, our distinguished guest speaker Dr. Roger Lo will provide insights into his current research on MAP kinase targeted therapies and checkpoint inhibitors for melanoma.

Join us for this GEN webinar where our guest presenters will share their experiences with 3D cell culture—from the development of tissue specific spheroids to new imaging modalities.

In this GEN webinar, our expert panelists will discuss how the timsTOF Pro mass spectrometry (MS) platform combines trapped ion mobility with a quadrupole, collision cell, and a TOF mass analyzer to probe ions at high speeds with on-the-fly fragmentation.

In this GEN webinar, our expert panelists will discuss the most recent data on how cryo-EM-enabled structural insights are guiding the development of novel strategies for rational drug design in serotonin (3A) receptors and glycine receptors.

Join this GEN webinar to learn how SARS-CoV-2 Reporter Virus Particles (RVPs, pseudotyped viruses) enable researchers to rapidly test neutralization titers of antibodies and vaccinee sera in a safe BSL-2 environment.